|
TSPAN14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.75499994934125E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.89980311669092E-11 |
| Normal-vs-Stage2 |
2.47079999999844E-05 |
| Normal-vs-Stage3 |
7.191600E-02 |
| Normal-vs-Stage4 |
1.015820E-01 |
| Stage1-vs-Stage2 |
3.899800E-01 |
| Stage1-vs-Stage3 |
8.791700E-02 |
| Stage1-vs-Stage4 |
1.826410E-01 |
| Stage2-vs-Stage3 |
3.210200E-01 |
| Stage2-vs-Stage4 |
5.174600E-01 |
| Stage3-vs-Stage4 |
8.404200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89860005495035E-09 |
| Normal-vs-AfricanAmerican |
2.16510000039527E-07 |
| Normal-vs-Asian |
1.012200E-02 |
| Caucasian-vs-AfricanAmerican |
9.054600E-01 |
| Caucasian-vs-Asian |
7.244600E-01 |
| AfricanAmerican-vs-Asian |
6.440600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08089981409876E-10 |
| Normal-vs-Female |
1.462360E-02 |
| Male-vs-Female |
7.299600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.20779999999809E-05 |
| Normal-vs-Extreme_Weight |
9.81179582026925E-11 |
| Normal-vs-Obese |
1.191710E-04 |
| Normal-vs-Extreme_Obese |
2.34368080498371E-13 |
| Normal_Weight-vs-Extreme_Weight |
1.363980E-01 |
| Normal_Weight-vs-Obese |
5.386000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.249600E-04 |
| Extreme_Weight-vs-Obese |
2.049900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.535800E-03 |
| Obese-vs-Extreme_Obese |
4.84879999995691E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.792800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.29029999912578E-08 |
| Normal-vs-Age(61-80Yrs) |
1.58300039743153E-10 |
| Normal-vs-Age(81-100Yrs) |
1.25910000203788E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.131210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.516200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.564360E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.492370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.799600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.401500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62470037423645E-12 |
| Normal-VS-Type2 PRCC |
6.71489974735096E-10 |
| Normal-VS-KIRP CIMP |
4.907800E-02 |
| Normal-VS-Unclassified PRCC |
4.10830000000528E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.691400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.619780E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.624600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.144000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.005150E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.358200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.34220420836095E-11 |
| Normal-vs-N1 |
7.469200E-01 |
| Normal-vs-N2 |
7.478000E-01 |
| N0-vs-N1 |
8.599000E-03 |
| N0-vs-N2 |
3.492600E-01 |
| N1-vs-N2 |
8.641800E-01 |
|
|
